Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole for Mood and Depression in RLS
NCT00357097Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ropinirole in restless legs syndrome (RLS), major depressive disorder (MDD), sponsored by GSK. Started Jun 2006; status: completed.
02
Drugs
ropinirole
03
Conditions
restless legs syndrome (RLS)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00357097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00357097.